Nuzenio

Kalkine Amplia Therapeutics

Kalkine Amplia Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 13:39:00 GMTAmplia Therapeutics (ASX:ATX) Firms As Market Watches Pancreatic Cancer Program - Kalkine
Fri, 07 Aug 2026 07:21:00 GMTAmplia Therapeutics Ltd (ASX: ATX) Share Price Update: Trading Activity and Biotechnology Sector Trends on August 7, 2026 - Kalkine
Tue, 04 Aug 2026 00:43:00 GMTAmplia Therapeutics (ASX: ATX) Announces Lilly Clinical Collaboration - Kalkine
Fri, 31 Jul 2026 07:00:00 GMTAmplia Therapeutics' Narmafotinib Pancreatic Cancer Study Published on bioRxiv - Kalkine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Kalkine Amplia Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.